Cost-effectiveness Analysis of implementing R21/Matrix-M Malaria vaccine in Kenya.
Starting on:
Jun 12, 2024
Ending on:
Jun 12, 2024
Moderator(s):
Venue:
KWTRP Nairobi campus, virtual for Kilifi staff
Max Credits:
3 Points

Provider:
KEMRI-WELLCOME TRUST RESEARCH PROGRAMME
Claim Points

Cost-effectiveness Analysis of implementing R21/Matrix-M Malaria vaccine in Kenya.

Starting on:
Jun 12, 2024
Ending on:
Jun 12, 2024
Venue:
KWTRP Nairobi campus, virtual for Kilifi staff

Description

Regular scientific seminar

Objectives

Cost-effectiveness Analysis of implementing R21/Matrix-M Malaria vaccine in Kenya.

Presenters

  1. Mr. Brian Arwah
    Brian Arwah is a Research Officer in the Health Economics Research Unit. He holds a Master of Science in Economic analysi
    KWTRP

Search For CPD Activity